Search Results - "Noguera, Gladys"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Peripheral Immunophenotype in IgG4-Related Disease and Its Association with Clinical Phenotypes and Disease Activity by Martín-Nares, Eduardo, Hernández-Molina, Gabriela, Priego-Ranero, Ángel A, Chan-Campos, Isela, Herrera-Noguera, Gladys S, López-Verdugo, Fidel, Furuzawa-Carballeda, Janette

    Published in Cells (Basel, Switzerland) (01-02-2023)
    “…Diverse immune cell subsets have been described in IgG4-related disease (IgG4-RD). If there is a different immunophenotype according to clinical phenotype and…”
    Get full text
    Journal Article
  2. 2

    Room Temperature Liquid Salts of Cr and Mo as Self-Supported Oxidants by Noguera, Gladys, Mostany, Jorge, Agrifoglio, Giuseppe, Dorta, Romano

    Published in Advanced synthesis & catalysis (01-02-2005)
    “…Room temperature liquid salts of Cr and Mo were synthesized and fully characterized including cyclic voltammetry of the neat Mo salt. These liquid salts were…”
    Get full text
    Journal Article
  3. 3

    A comparative activity study of a new ultra-dispersed catalyst system for a hydrocracking/hydrotreating technology using vacuum residue oil: Merey/Mesa by Noguera, Gladys, Araujo, Solange, Hernández, Javier, Rivas, Angel, Mendoza, Dietrich, Castellano, Olga

    Published in Chemical engineering research & design (01-11-2012)
    “…▸ Ultra-dispersed emulsions used in a hydroconversion process for heavy crudes. ▸ Catalytic activity comparison of two formulations, with changes in…”
    Get full text
    Journal Article
  4. 4

    First Dioxomolybdenum(VI) Complexes Containing Chiral Oxazoline Ligands: Synthesis, Characterization and Catalytic Activity by Gómez, Montserrat, Jansat, Susanna, Muller, Guillermo, Noguera, Gladys, Teruel, Helena, Moliner, Vicent, Cerrada, Elena, Hursthouse, Michael

    Published in European journal of inorganic chemistry (01-04-2001)
    “…The cis‐[MoO2(N,O)2] complexes containing chiral oxazoline ligands (N,O) [1: N,O = A, (4′R)‐2‐(4′‐ethyl‐3′,4′‐dihydroxazol‐2′‐yl)phenolato; 2: N,O = B,…”
    Get full text
    Journal Article